+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Transdermal Drug Delivery System Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type; Application; End User

  • PDF Icon

    Report

  • 174 Pages
  • August 2020
  • Region: Europe
  • The Insight Partners
  • ID: 5147230
UP TO OFF until Jun 30th 2024
The Europe transdermal drug delivery system market is expected to reach US$ 2,060.00 million by 2027 from US$ 1,524.63 million in 2019; it is estimated to grow at a CAGR of 4.0% from 2020 to 2027.

The growth of the market in this region is attributed to the increasing prevalence of chronic diseases, growing demand for non-invasive drug delivery devices, and high preference for self-administration of drugs. However, the elevated costs of the development of drug delivery systems, and failure and recalls of transdermal drug delivery systems hinder the growth of the market.

Germany in the largest European market for transdermal drug delivery systems, and its growth is mainly credited to the increasing investments in R&D for the development of innovative drug delivery systems. The Nose-to-Brain-patch (N2B-patch), an EU-funded project, aims to develop an innovative technology for multiple sclerosis (MS) treatment by developing a “nose to brain” delivery system for painless drug delivery.

The Europe transdermal drug delivery system market based on type is has been segmented into transdermal patch and transdermal semisolids. The market for the transdermal patch segment is subsegmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and micro needle patches. The market for the transdermal semisolids segment is further segmented into gels, ointments, and sprays. The transdermal patch segment held a larger share of the market in 2019, and it is anticipated to register a higher CAGR during the forecast period. The Europe transdermal drug delivery system market based on application has been segmented into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The market for hormonal applications is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2019, and it is likely to register the highest CAGR during the forecast period. On the basis of end user, the transdermal drug delivery system market has been segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the market in 2019; however, the market for home care settings is expected grow at the highest CAGR during the forecast period.

A few major primary and secondary sources referred to while preparing the report on the Europe transdermal drug delivery system market are the World Health Organization (WHO), European Medicines Agency, and European Centre for Disease Prevention and Control.

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Europe Transdermal Drug Delivery System Market- By Type
1.3.2 Europe Transdermal Drug Delivery System Market- By Application
1.3.3 Europe Transdermal Drug Delivery System Market- By End User
1.3.4 Europe Transdermal Drug Delivery System Market- By Region
2. Transdermal Drug Delivery System Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Transdermal Drug Delivery System - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe
4.3 Expert Opinion
5. Europe Transdermal Drug Delivery System Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 High Demand for Self-Administration of Drugs
5.2 Market Restraints
5.2.1 Drug Failure and Recalls of Transdermal Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Strategic Activities by the Manufacturers
5.4 Future Trends
5.4.1 Rise in Adoption of Third-Generation Delivery Systems
5.5 Impact Analysis
6. Transdermal Drug Delivery System Market - Regional Analysis
6.1 Europe Transdermal drug delivery system Market Revenue Forecast And Analysis
7. Transdermal Drug Delivery System Market Analysis - By Type
7.1 Overview
7.2 Transdermal Drug Delivery System Market Revenue Share, by Type, 2019 and 2027 (%)
7.2.1.1 Europe Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
7.3 Transdermal Patch
7.3.1 Overview
7.3.2 Transdermal Patch: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Drug-In-Adhesive Patches
7.3.4 Overview
7.3.5 Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Matrix Patches
7.3.7 Overview
7.3.8 Reservoir Membrane Patches
7.3.9 Overview
7.3.10 Reservoir Membrane Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.3.11 Microneedle Patches
7.3.12 Overview
7.3.13 Microneedle Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Transdermal Semisolids
7.4.1 Overview
7.4.2 Transdermal Semisolids: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Gel
7.4.4 Overview
7.4.5 Gel: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Sprays
7.5.1 Overview
7.5.2 Sprays: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Ointments
7.6.1 Overview
7.6.2 Ointments: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8. Transdermal Drug Delivery System Market - By Application
8.1 Overview
8.2 Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)
8.2.1 Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.3 Cardiovascular Diseases
8.3.1 Overview
8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Central Nervous System Disorders
8.4.1 Overview
8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Pain Management
8.5.1 Overview
8.5.2 Pain Management: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Hormonal Applications
8.6.1 Overview
8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.6.3 Transdermal Estrogen Therapy
8.6.4 Overview
8.6.5 Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.6.6 Testosterone Replacement
8.6.7 Overview
8.6.8 Testosterone Replacement: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
9. Transdermal Drug Delivery System Market - By End User
9.1 Overview
9.2 Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)
9.2.1 Europe Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
9.5.3 Other End Users: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
10. Transdermal Drug Delivery System Market- Regional Analysis
10.1 Europe: Transdermal Drug Delivery System Market
10.1.1 Overview
10.1.2 Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Europe Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Europe Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.4 Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.4.1 Europe Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.5 Europe Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.6 Europe: Transdermal Drug Delivery System Market, by Country, 2019 & 2027 (%)
10.1.7 Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.2.1 Germany Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.2.2 Germany Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Germany Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.7.3.1 Germany Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Germany Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.8 UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UK Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.2.1 UK Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.2.2 UK Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 UK Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.8.3.1 UK Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.4 UK Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.9 France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 France Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.1 France Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.2 France Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 France Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.9.3.1 France Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 France Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.10 Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Spain Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.10.2.1 Spain Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.10.2.2 Spain Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.10.3 Spain Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.10.3.1 Spain Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.10.4 Spain Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.11 Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Italy Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.11.2.1 Italy Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.11.2.2 Italy Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Italy Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.11.3.1 Italy Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Italy Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Transdermal Drug Delivery System Market
11.1 Europe: Impact assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Novartis AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GlaxoSmithKline plc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bayer AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Lavipharm
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Tables
Table 1. Europe Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Europe Transdermal Drug Delivery System Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 3. Europe Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. Europe Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Europe Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Europe Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Europe Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 8. Europe Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Europe Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Germany Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Germany Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Germany Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 13. Germany Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 14. Germany Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Germany Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. UK Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. UK Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 18. UK Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. UK Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. UK Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. UK Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 22. France Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. France Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 24. France Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 25. France Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 26. France Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 27. France Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 28. Spain Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 30. Spain Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 31. Spain Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. Spain Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Spain Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. Italy Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Italy Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Italy Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 40. Glossary of Terms, Transdermal Drug Delivery System Market
List of Figures
Figure 1. Transdermal Drug Delivery System Market Segmentation
Figure 2. Transdermal Drug Delivery System Segmentation – By Region
Figure 3. Europe Transdermal Drug Delivery System Market Overview
Figure 4. Transdermal Patches Segment Held Largest Share of Transdermal Drug Delivery System Market
Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Europe Transdermal Drug Delivery System Market – Revenue Forecast And Analysis – 2019- 2027
Figure 8. Transdermal Drug Delivery System Market Revenue Share, by Type, 2019 and 2027 (%)
Figure 9. Transdermal Patch: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 10. Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Microneedle Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Transdermal Semisolids: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Gel: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Ointments: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)
Figure 19. Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Other Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)
Figure 27. Hospitals and Clinics: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Home Care Settings: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Europe: Transdermal Drug Delivery System Market, by Key Country – Revenue (2019) (USD Million)
Figure 30. Europe Transdermal Drug Delivery System Market Revenue and Forecast to 2027 (USD Million)
Figure 31. Europe: Transdermal Drug Delivery System Market, by Country, 2019 & 2027 (%)
Figure 32. Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Impact of COVID-19 Pandemic In Europe Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novartis AG
  • Boehringer Ingelheim International GmbH
  • Lavipharm
  • GlaxoSmithKline plc
  • Bayer AG